Search IconSearch
November 8, 2021/Neurosciences/Epilepsy

How Do SEEG and Subdural Electrodes Stack Up for Epilepsy Surgery Evaluation?

International registry study finds SEEG involves less morbidity, greater chance of seizure freedom


Compared with stereotactic electroencephalography (SEEG), subdural electrode (SDE) evaluation of patients with drug-resistant epilepsy is likelier to lead to therapeutic resection but entails more surgical complications and is less likely to result in freedom from seizures. So concludes an international team of investigators who analyzed a large registry of patients who underwent either of these procedures.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The study, published online in the Annals of Neurology, provides the strongest evidence to date comparing these two intracranial procedures for epilepsy localization.

“Our robust statistical approach using propensity score matching enabled us to create comparable treatment arms from registry data,” says first and corresponding author Lara Jehi, MD, an epileptologist and Chief Research Information Officer at Cleveland Clinic. “The results provide us with the highest feasible evidence level to guide decisions on using these invasive tools.”

Two important approaches…

While resection is the best treatment for drug-resistant focal epilepsy, a surgical plan cannot always be developed using noninvasive tests. In such cases, the following two major approaches are available to obtain intracranial EEG recordings:

  • SDE implantation. Although this method is more invasive, requiring craniotomy, it offers the chance of resection during the same hospitalization. Recording predominantly covers the cortical surface and allows for more straightforward mapping of functional eloquent cortex.
  • SEEG. This method uses less invasive burr holes but typically requires a separate admission six weeks later if brain surgery will be performed. It allows for investigation of deeper structures — which often account for seizure recurrence after surgery — than the SDE method.


Both approaches require complex technical resources and are associated with significant risks and costs as well as prolonged hospitalization. Because they also require different neurosurgical expertise and technical support, not many institutions offer both options. And programs that do have the capability for both tend to develop particular expertise in one, giving their providers a strong preference for that option.

…not previously compared rigorously

“Clinical practice in this realm is preference-sensitive rather than evidence-based,” Dr. Jehi observes. “But obtaining evidence through a randomized clinical trial comparing the two methods is virtually impossible.” She cites two major reasons for this situation: only a few programs offer both procedures, and patients often have strong preferences about which method they want.

Although a few retrospective descriptive case series comparing the two methods have been published, the patient cohorts are generally too different at baseline to allow for meaningful comparisons, Dr. Jehi notes. She adds that this reflects the belief — based on expert consensus recommendations with no available class 1 or 2 evidence — that specific clinical settings are better suited to one method over another.

Study design and findings

The study drew from an international registry governed by the Surgical Therapies Commission of the International League Against Epilepsy. The registry was created under Dr. Jehi’s leadership as commission chair to study outcomes of patients with drug-resistant epilepsy undergoing intracranial EEG. The 10 participating sites, including Cleveland Clinic, were selected to ensure uniformity in neurosurgical standards. Patients were at least 16 years old at the time of surgical evaluation and were followed for at least one year after evaluation.

The cohort consisted of 526 patients who underwent SDE and 942 who underwent SEEG between 2005 and 2019. Of the total of 1,468 patients, 988 (67%) underwent subsequent resection.

Propensity score matching was used to create statistically comparable cohorts to approximate a randomized clinical trial using observational data. Eighteen variables were used in the analyses of resection and seizure outcomes (e.g., seizure frequency, MRI findings, age and epilepsy duration); eight variables were used in the analysis of complications.

Analyses of propensity-matched groups revealed the following differences in outcomes between the two methods:

  • SDE was likelier to lead to subsequent resective surgery compared with SEEG (odds ratio [OR] = 1.39; 95% CI, 1.05-1.84).
  • SDE was likelier to involve complications than SEEG (OR = 2.24; 95% CI, 1.34-3.74), with the difference mostly due to postoperative infection in the SDE group.
  • SEEG was more likely than SDE to lead to seizure freedom (OR = 1.66; 95% CI, 1.21-2.26).


Complexity makes definitive choice unlikely

Although propensity matching allows for controlling of many variables, Dr. Jehi emphasizes that it is impossible at this point to conclude that one method is preferable in all cases. Some patients are more risk averse, while others are unwilling to delay surgery or undergo two hospitalizations. In addition, certain clinical scenarios — e.g., involving the likely location of a lesion — may also help determine the best evaluative approach.

“Our findings of the superiority of one method over another should inform decision-making but do not override other factors, such as local expertise and patient circumstances,” Dr. Jehi concludes. “The most important considerations are accomplishing surgery expeditiously and safely.”

She adds that additional studies using these statistical techniques are expected to further clarify choices when randomized clinical trials are not feasible.


Related Articles

schematic view of brain connections during an epileptic seizure
April 5, 2024/Neurosciences/Epilepsy
New Insights on the Dynamics of Interictal-to-Ictal Transitions in Epilepsy

Study combines intracranial electrophysiology and SPECT to elucidate the role of hypoperfusion

DNA gel showing genetic sequencing
February 20, 2024/Neurosciences/Epilepsy
Large GWAS Meta-Analysis Identifies Multiple New Genetic Risk Factors for Epilepsy

Characterizing genetic architecture of clinical subtypes may accelerate targeted therapy

January 11, 2024/Neurosciences/Epilepsy
Managing Seizure Risk After Stroke: Who Needs Antiseizure Meds, and for How Long?

Many patients unnecessarily continue the medications for years

December 7, 2023/Neurosciences/Epilepsy
Dr. Elaine Wyllie Shares Insights From a Singular Career in Epilepsy Medicine

Pre-retirement reflections from a pioneering clinician, researcher and educator

August 25, 2022/Neurosciences/Epilepsy
Referral for Epilepsy Surgery Evaluation: Earlier Is Better in Most Cases, Expert Panel Says

ILAE advises emphasizing options for patients with drug-resistant epilepsy

August 23, 2022/Neurosciences/Epilepsy
Black Line Sign Shows Promise as a Noninvasive Marker for Focal Cortical Dysplasia IIB

Mounting support for the newly described microstructure from a 7T MRI and electroclinicopathologic study

August 15, 2022/Neurosciences/Epilepsy
Psychogenic Nonepileptic Seizure: A Neurologist’s Perspective

Confirming the diagnosis is only the start of the journey

Ganaxolone Effective for Rare Form of Childhood Epilepsy (1)
April 11, 2022/Neurosciences/Epilepsy
Ganaxolone Effective for Rare Form of Childhood Epilepsy

The neuroactive steroid significantly reduces seizures related to CDKL5 deficiency disorder